1,507
Views
9
CrossRef citations to date
0
Altmetric
Clinical Study

Contribution of volume overload to the arterial stiffness of hemodialysis patients

, , , &
Pages 333-339 | Received 22 Oct 2016, Accepted 29 Dec 2016, Published online: 24 Jan 2017

References

  • Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305.
  • Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59:e1–e420.
  • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–1357.
  • Boutouyrie P, Fliser D, Goldsmith D, et al. Assessment of arterial stiffness for clinical and epidemiological studies: Methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. Nephrol Dial Transplant. 2014;29:232–239.
  • Kalantar–Zadeh K, Regidor DL, Kovesdy CP, et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation. 2009;119:671–679.
  • Hung SC, Kuo KL, Peng CH, et al. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease. Kidney Int. 2014;85:703–709.
  • Kosch M, Levers A, Barenbrock M, et al. Acute effects of haemodialysis on endothelial function and large artery elasticity. Nephrol Dial Transplant. 2001;6:1663–1668.
  • Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA. Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol. 2002;13:177–183.
  • Ie EH, De Backer TL, Carlier SG, et al. Ultrafiltration improves aortic compliance in haemodialysis patients. J Hum Hypertens. 2005;19:439–444.
  • Covic A, Goldsmith DJ, Gusbeth-Tatomir P, Covic M. Haemodialysis acutely improves endothelium-independent vasomotor function without significantly influencing the endothelium-mediated abnormal response to a beta 2-agonist. Nephrol Dial Transplant. 2004;19:637–643.
  • Su HM, Chang JM, Lin FH, et al. Influence of different measurement time points on brachial– ankle pulse wave velocity and anklebrachial index in hemodialysis patients. Hypertens Res. 2007;30:965–970.
  • Di Iorio B, Nazzaro P, Cucciniello E, Bellizzi V. Influence of haemodialysis on variability of pulse wave velocity in chronic haemodialysis patients. Nephrol Dial Transplant. 2010;25:1579–1583.
  • Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–1327.
  • Gusbeth-Tatomir P, Covic A. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Kidney Blood Press Res. 2007;30:97–107.
  • Chung AW, Yang HH, Kim JM, et al. Arterial stiffness and functional properties in chronic kidney disease patients on different dialysis modalities: An exploratory study. Nephrol Dial Transplant. 2010;25:4031–4041.
  • Palmer BF, Henrich WL. Recent advances in the prevention and management of intradialytic hypotension. J Am Soc Nephrol. 2008;9:8–11.
  • Van Bortel LM, Laurent S, Boutouyrie P, et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30:445–448.
  • Van Bortel LM, Duprez D, Starmans–Kool MJ, et al. Clinical applications of arterial stiffness, Task Force III: Recommendations for user procedures. Am J Hypertens. 2002;15:445–452.
  • Wizemann V, Wabel P, Chamney P, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009;24:1574–1579.
  • Wabel P, Moissl U, Chamney P, et al. Towards improved cardiovascular management: The necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008;23:2965–2971.
  • Chazot C, Jean G. Intradialytic hypertension: It is time to act. Nephron Clin Pract. 2010;115:182–188.
  • Gũnal AI, Karaca I, Celiker H, Ilkay E, Duman S. Paradoxical rise in blood pressure during ultrafiltration is caused by increased cardiac output. J Nephrol. 2002;15:42–47.
  • Cirit M, Akçiçek F, Terzioğlu E, et al. 'Paradoxical' rise in blood pressure during ultrafiltration in dialysis patients. Nephrol Dial Transplant. 1995;10:1417–1420.
  • Georgianos PI, Sarafidis PA, Malindretos P, Nikolaidis P, Lasaridis AN. Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients. Am J Nephrol. 2011;34:407–414.
  • Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163–168.
  • Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: Prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158:659–666.
  • Yoon HE, Kim SJ, Hwang HS, Chung S, Yang CW, Shin SJ. Progressive rise in red blood cell distribution width predicts mortality and cardiovascular events in end-stage renal disease patients. PLoS One. 2015;10:e0126272.